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Abstract: Background
Both maternal obesity and disordered mood have adverse effects on pregnancy
outcome. We hypothesized that maternal very severe obesity (SO) is associated with
increased anxiety and depression (A&D) symptoms during pregnancy, with adverse
effects on gestational weight gain (GWG), postpartum mood and postpartum weight
retention (PPWR) and explored any mediation by circulating glucocorticoids.
Methods
We measured A&D symptoms with validated questionnaires at week 17 and 28
pregnancy and 3 months postpartum in 135 lean (BMI ≤25 kg/m2) and 222 SO (BMI
≥40 kg/m2) pregnant women. Fasting serum cortisol was measured by
radioimmunoassay; GWG and PPWR were recorded.
Results
A&D symptoms were higher in SO group during pregnancy and postpartum despite
adjusting for multiple confounders including previous mental health diagnosis (p<0.05),
and were non-linearly correlated with total GWG (R2 = 0.06, p=0.037; R2 = 0.09,
p=0.001, respectively). In SO group only, increased maternal anxiety (β= 0.33, p=0.03)
and depression (β=0.19, p=0.04) symptoms at week 17 pregnancy were associated
with increased PPWR, independent of total GWG and breastfeeding. Anxiety
symptoms at week 28 pregnancy, but not depression, were non-linearly correlated with
serum cortisol level at week 36 pregnancy (R2 = 0.06, p=0.02). Cortisol did not
mediate the link between A&D symptoms and GWG.
Conclusions
Maternal SO was associated with increased A&D symptoms, with adverse effects on
GWG and PPWR independent of circulating glucocorticoids. Strategies to optimise
GWG and postpartum weight management in SO women should include assessment
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of maternal mood in early pregnancy.
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Abstract 
Background 
Both maternal obesity and disordered mood have adverse effects on pregnancy outcome. We 
hypothesized that maternal very severe obesity (SO) is associated with increased anxiety and 
depression (A&D) symptoms during pregnancy, with adverse effects on gestational weight 
gain (GWG), postpartum mood and postpartum weight retention (PPWR) and explored any 
mediation by circulating glucocorticoids. 
Methods 
We measured A&D symptoms with validated questionnaires at week 17 and 28 pregnancy 
and 3 months postpartum in 135 lean (BMI ≤25 kg/m2) and 222 SO (BMI ≥40 kg/m2) 
pregnant women. Fasting serum cortisol was measured by radioimmunoassay; GWG and 
PPWR were recorded. 
Results 
A&D symptoms were higher in SO group during pregnancy and postpartum despite adjusting 
for multiple confounders including previous mental health diagnosis (p<0.05), and were non-
linearly correlated with total GWG (R
2 
= 0.06, p=0.037; R
2 
= 0.09, p=0.001, respectively). In 
SO group only, increased maternal anxiety (β= 0.33, p=0.03) and depression (=0.19, 
p=0.04) symptoms at week 17 pregnancy were associated with increased PPWR, independent 
of total GWG and breastfeeding. Anxiety symptoms at week 28 pregnancy, but not 
depression, were non-linearly correlated with serum cortisol level at week 36 pregnancy (R
2 
= 
0.06, p=0.02). Cortisol did not mediate the link between A&D symptoms and GWG. 
Conclusions 
Maternal SO was associated with increased A&D symptoms, with adverse effects on GWG 
and PPWR independent of circulating glucocorticoids. Strategies to optimise GWG and 
postpartum weight management in SO women should include assessment of maternal mood 
in early pregnancy. 
Introduction 
Depression during pregnancy is common, occurring in 6.5%- 12.9% of women worldwide 
(Gavin et al., 2005), though symptoms are often under- reported (Boots Family Trust 
Alliance, 2013). A recent meta-analysis showed that women with higher Body Mass Index 
(BMI) are at greater risk of anxiety and depression (A&D) symptoms (Odds Ratio (OR) [95% 
Confidence Interval] = 1.41 [1.10-1.80] and 1.43 [1.26-1.61], respectively) during pregnancy 
compared to normal-weight women (Molyneaux et al., 2014). This is of concern as 1 in 5 
women in the UK are obese at antenatal booking (Heslehurst et al., 2010). Moreover, 
maternal obesity and mood disorders have been independently shown to associate with 
various obstetric complications, poorer birth outcomes, infant health (Lawlor et al., 2012; 
Alder et al., 2007), cognitive and behavioural development (Mina and Reynolds, 2014) and 
increased risk of postpartum depression (Molyneaux et al., 2014).  
Excess gestational weight gain (GWG) is closely linked with maternal obesity 
(Institute of Medicine, 2009). Both maternal obesity and excessive GWG increase the risk of 
adverse obstetric outcomes such as gestational diabetes mellitus (GDM), macrosomia, 
stillbirth, and excessive postpartum weight retention (PPWR) (Norman and Reynolds, 2011). 
These in turn associate with increased risk of complications in further pregnancies, and risk 
of future metabolic and cardiovascular disorders in mother (McClure et al., 2013) and 
offspring (Reynolds et al., 2013). Nevertheless, approximately 20-40% of women exceed 
recommended international guidelines for GWG (Crozier et al., 2009). 
Psychosocial and/or psychological factors may explain the limited outcomes 
identified in a meta-analysis of randomised trials of lifestyle interventions aimed at reducing 
excessive GWG in obese pregnancy (Gardner et al., 2011). Obese pregnant women also 
reported an unwillingness to discuss weight issues with health professionals (Strychar et al., 
2000) and a negative attitude towards weight gain (DiPietro et al., 2003). Mood is known to 
influence weight gain in non-pregnancy (Luppino et al., 2010) and GWG has been linked 
with increased risk of major depressive disorder during pregnancy (Bodnar et al., 2009), but 
most lifestyle interventions in pregnancy have not addressed maternal mood symptoms such 
as A&D. 
Recently a randomised trial using a motivational interview in obese pregnant women 
was found to reduce both GWG and the level of anxiety (Bogaerts et al., 2013b). Although 
this strongly implies that maternal mood symptoms influence weight in obese pregnancy, 
these findings are in contrast with observations in populations of low-income women with 
lower rates of obesity, where higher psychosocial stress predicts lower GWG (Winkvist et al., 
2002; Ota et al., 2011). Therefore in order to better understand how GWG and PPWR are 
influenced by mood symptoms, we need to simultaneously consider the effect of both 
maternal obesity and mood symptoms including A&D. 
Mechanisms linking obesity with increased A&D remain unclear, but both are known 
to share many dysregulated biological pathways in non-pregnant individuals. These include 
altered homeostasis of neurotransmitters, metabolism, inflammation, clearance of oxidative 
stress, and altered hypothalamic pituitary adrenal (HPA) axis activity (Lopresti and 
Drummond, 2013). In healthy pregnancy, the maternal HPA axis undergoes dramatic changes 
with circulating cortisol levels rising three-fold higher than in non-pregnancy (Mastorakos 
and Ilias, 2003), yet our recent studies show cortisol levels are lower on obese pregnancy 
(Stirrat et al, 2014). Whether alterations in circulating glucocorticoids underpin the link 
between maternal obesity and mood symptoms in pregnancy is unknown.  
We hypothesized that firstly, maternal obesity would be associated with increased 
A&D symptoms during pregnancy even after adjusting for an array of obesity-linked and/or 
mood-linked confounders. Secondly, the predicted increased A&D symptoms in obese 
pregnancy would be associated with increased GWG, postpartum A&D symptoms and 
increased PPWR. Thirdly, the increased A&D symptoms in obese pregnancy would correlate 
with increased circulating cortisol levels. We aimed to test these hypotheses in a prospective 
case-control study of over 200 very Severely Obese (SO) women (WHO obese class III, BMI 
≥ 40 kg/m2) and lean controls who were assessed for symptoms of both A&D during the 
antenatal and postnatal period and were characterised in detail during pregnancy.  
Methods 
 
Participants 
Women identified during their first community midwifery visit as having a BMI ≥40 kg/m2 
(SO)
 
were referred to the Antenatal Metabolic Clinic (AMC), Simpson’s Centre for 
Reproductive Health, Royal Infirmary of Edinburgh. These women, and lean controls with 
BMI ≤25 kg/m2 at booking antenatal visit, were invited to participate in a prospective case-
control study from 2008 to 2013. Ethical approval and written informed consent were 
obtained (reference: 08/S1101/39).  
All women were weighed at week ~17, ~28 and ~36 of pregnancy and at 3 months 
postpartum (TANITA scales BC-418MA, TANITA Ltd). We defined total GWG as body 
weight at 36 – 17 weeks pregnancy, and used the 2009 IOM guidelines to categorise total 
GWG (obese women BMI ≥ 30 kg/m2: recommended GWG = 4.9 -9.1 kg; normal weight 
women BMI 18-25 kg/m
2
: recommended GWG = 11-16 kg). Women with SO were reviewed 
by a specialized dietician and advised about healthy eating and about how to maintain their 
weight during pregnancy. Community midwives discussed diet and exercise with lean 
controls during pregnancy. PPWR was defined as – (postnatal weight loss) = weight at 36 
weeks gestation – weight at postnatal visit. A greater difference indicates lower PPWR. 
We evaluated various demographic factors preceding pregnancy (collectively termed 
maternal factors) and those arising during pregnancy (collectively termed pregnancy factors) 
which potentially influence maternal mood during pregnancy and may confound the analyses 
of mood assessment through questionnaire and verified the data with hospital records. 
Questions about traumatic obstetric history (Mota et al., 2010), reproductive problems 
(Stanton et al., 2002), and inflammatory disorders (Rosenblat et al., 2014) were included as 
these have been independently shown to affect non-pregnant women’s mood. Information 
about major obstetric complications including gestational diabetes (GDM) and pre-eclampsia 
was extracted from the maternity records. Women identified their minor pregnancy 
complications from lists provided in the questionnaire: symphysis pubic dysfunction, chest 
infection, heartburn, headache, carpal tunnel syndrome, constipation, sciatica, hyperemesis 
and urinary tract infection. 
Breastfeeding is known to reduce PPWR. Women were given a questionnaire about 
breast-feeding habits at the postnatal visit alongside mood assessments. A component of the 
questionnaire— responses to the question “Are you breastfeeding your baby now? 
(yes/no)”— was included for the subsequent analysis. A “yes” answer included both 
exclusive breastfeeding and a mix of breastfeeding and bottle-feeding with infant formula. 
 
Mood assessments 
Questionnaires were administered at the first study visit (~week 17 pregnancy; visit 1), 
~week 28 of pregnancy (visit 2) and at the postpartum visit. The questionnaires comprised 5 
previously validated self-rating items in printed format: 1) psychosocial risk factor 
assessment (Rosengren et al., 2004); 2) Satisfaction with Life Scale (SWLS) (Diener et al., 
1985); 3) General Health Questionnaire (GHQ) (Goldberg, 1972); 4) Hospital Anxiety and 
Depression Scale (HADS) (Zigmond and Snaith, 1983) and 5) State-Trait Anxiety Index 
(STAI) (Spielberger, 1927). Total scores from each questionnaire and their clinical cut-offs 
were considered for further analysis. 
The psychosocial risk factor assessment measures perceived stress at home, at work 
and financial stress using scales of “never”, “some of the time”, “several periods” and 
“severe”. We also asked about the occurrence of stressful major life events such as divorce, 
job dismissal, and bereavement. Participants’ response to this section was later categorised 
into “none” or “1 and/or more major life events”. 
SWLS uses 1-7 Likert scale (1= strongly disagree, 7= strongly agree, range: 5-35), 
and was previously validated in a longitudinal pregnancy population (Dyrdal et al., 2010). 
Chronbach’s  for the lean group was 0.929, 0.905, and 0.89 for 17 and 28 gestational weeks 
and postpartum respectively. A score ≤19 was used to define life satisfaction as “slightly 
below average”. 
GHQ-12 uses binary scoring (range: 0-15). A cut-off score of 3 and 4 was 
recommended by WHO for the UK population (Goldberg et al., 1997), but since a cut-off of 
4 has been shown not to differentiate stress levels between pregnant and non-pregnant 
controls (Bussel et al., 2006), we used a cut-off of 3 in this study. 
HADS evaluates A&D symptoms (range: 0-21 each) and has been reported to help in 
differentiating transient and enduring stress during pregnancy (Matthey and Ross-Hamid, 
2012). A score ≥10 per component was used to indicate high risk of clinical A&D. 
STAI evaluates both state (transient) and trait (persistent) anxiety (range: 20-80 each), 
and has been previously validated in pregnant women with SO (Gunning et al., 2010). A cut-
off of 39 per component was used to indicate high risk of clinical anxiety. 
A single question “Have you consulted your General Practitioner (GP) about mood 
issues in the last 2 years?” was included. Hospital records were used to verify previous 
history of mood disorders, and where applicable, the type and status of the diagnosis, 
counselling attendance and/or treatment with antidepressants or anxiolytic medication. At the 
same time-points, the risk of sleep apnoea and daytime sleepiness were evaluated using self-
rating paper questionnaires containing Berlin Sleep Questionnaire (Netzer et al., 1999) and 
Epworth Sleepiness Scale (ESS, Johns, 1991), respectively. This is because sleep disordered- 
breathing strongly associates with mood disorders (Alvaro et al., 2011), and increasingly 
observed in obese pregnancy (Maasilta et al., 2001). 
The researcher (THM) was blinded to participants’ SO/lean status during the scoring 
of mood questionnaires. 
 
Serum cortisol measurement 
Serum cortisol levels was measured with radioimmunoassay (RIA) using ImmuChem 
Cortisol 
125I kit (ICN Biomedicals, California, USA) as per the manufacturer’s protocol in 
fasting maternal samples collected at 9am during the first visit (week 17), week 28 and 36 of 
pregnancy (Stirrat et al., 2014). The intra- and inter- assay coefficients of variation were 6.1% 
- 8.9% and 7.6%- 9.3% (low- high concentrations), respectively.  
 
Statistical Analyses 
Statistical analyses were performed using SPSS 19 (IBM, New York, USA) and figures 
drawn with SPSS 19 and Graphpad 6 (Graphpad Software Inc., La Jolla, USA). Prior to any 
analyses, data distribution was determined by Q-Q Plot and by histogram visualisation. 
Where required, the data were log-transformed. P≤0.05 was used as a cut-off of statistical 
significance for descriptive data. 
Regression analyses were carried out with BMI as independent variable and each 
mood assessment scores and other potential confounders as dependent variable for each study 
time-point. Linear regression analyses were performed to adjust for demographic factors 
preceding pregnancy (maternal factors, p
1
), during pregnancy (pregnancy factors, p
2
), and 
both (p
3
).  Previous history of mood diagnosis was further considered by: 1) omitting 
participants with a previous mental health diagnosis (p
4
) and 2) performing further linear 
regression adjusting for history of mental health diagnosis (p
5
). Mood assessments data were 
also analysed using clinical cut-offs for each questionnaire using logistic regression. 
In testing the correlations among maternal mood, GWG, PPWR and serum cortisol 
levels, maternal mood outcomes were grouped into “anxiety symptoms” and “depression 
symptoms”. Anxiety symptoms were represented by Hospital Anxiety (HA from HADS) and 
STAI, whilst depression outcomes were represented by Hospital Depression (HD, from 
HADS) and GHQ. To avoid multiple testing and the need for including a Bonferonni 
correction, the z-score was calculated for each outcome and we used averaged z-scores for 
each symptom group in the analysis. We confirmed that the z-scores reflected the general 
observations that A&D symptoms are highly correlated across week 17 and 28 pregnancy (all 
Pearson’s correlation <0.7, p ≤0.0001) and that generally the SO group displayed poorer 
mood outcomes (S Table 1). 
Linear and quadratic curve-fitting were used to test whether there was any non-linear 
relationship between z-score anxiety and z-score depression with GWG and PPWR. 
MEDCURVE SPSS plug-in (http://www.afhayes.com/) was used to test whether there was 
any non-linear mediation by serum cortisol levels. 
Results 
Subject characteristics and confounding factors 
The population of this study included all women with singleton pregnancies that completed 
mood assessments during pregnancy in the cohort—135 lean and 222 SO women. Table 1 
presents the characteristics of the participants. Although the SO group were heavier than the 
lean group at each time-point, they had significantly lower GWG. 
SO group were younger, had higher parity, and were less affluent. They consumed 
less units of alcohol preceding pregnancy, but were more likely to smoke during pregnancy 
than the controls. There were no significant differences between lean and SO in other 
possible sources of maternal stress preceding the current pregnancy (Table 1). More 
participants in SO group developed GDM than in the lean group, but the rates of 
preeclampsia were similar. SO group reported a greater number of minor obstetric 
complications, and an increased risk of developing sleep disordered breathing than lean 
during pregnancy (Table 1). 
More SO women had a history of a prior mental health diagnosis, which was 
dominated by depression (Table 2).  However, the proportion of clinically active symptoms 
and antidepressants prescriptions at the first antenatal booking were similar between groups. 
The response to the direct question “Have you consulted GP about mood issues in the last 2 
years?” was consistent with the hospital records (Table 2). Altogether SO group had more 
maternal and pregnancy factors which have been recognised to negatively influence maternal 
mood. 
 
 
 SO women had higher psychosocial stress and lower mood throughout pregnancy even 
after adjusting for confounding factors 
SO mothers had a higher proportion of unemployment and higher finance-related stress 
(Table 3). When the unemployed individuals were excluded from the analysis, the work-
related stress was higher among SO mothers (p=0.013). More SO mothers also experienced 1 
or more traumatic life events preceding pregnancy. 
In unadjusted analyses SO mothers were less satisfied with life and had higher A&D 
symptoms during pregnancy (P
1
, Table 3). Adjusting for pregnancy factors reduced the 
significance of SWLS and HADS at visit 2 (P
3
, Table 3), however the SO group generally 
displayed poorer results in mood assessment during pregnancy (P
4
, Table 3). Analysing the 
data using clinical cut-off values of each questionnaire revealed that SO mothers were still at 
higher risks of A&D symptoms (P
1
, S Table 2). Adjusting for maternal and/or pregnancy 
factors reduced the significance of SWLS, HADS and STAI (P
2
, P
3
, P
4
, S Table 2), implying 
that maternal and/or pregnancy factors may play a larger role in influencing mood in SO 
participants with higher levels of anxiety. GHQ remained significant even after adjusting for 
both maternal and pregnancy factors (P
4
, S Table 2). 
Based on the results of the direct question and hospital records, we investigated 
whether the poorer mood assessment result in SO group was independent of participants’ 
previous history of mental health diagnosis. We observed similar findings when we either 
included adjustment for- or excluded individuals with- a previous history of mental health 
diagnosis (Table 3). We concluded that SO prior to pregnancy was independently associated 
with higher A&D symptoms throughout pregnancy, independent of various demographic and 
pregnancy factors and previous history of mental health diagnosis. 
 Postpartum mood outcomes 
The overall study attrition rate at postnatal follow-up for each group was approximately 30% 
(CONSORT table, S Fig 1). Women who attended for postnatal follow-up had better mood 
symptom scores during pregnancy than those who did not attend. In particular, SO women 
reported significantly better mood scores at the second visit in all domains other than HD 
than those who did not attend for follow-up (S Table 3). Despite this SO was associated with 
increased postpartum A&D symptoms compared to lean (P
4
, Table 3) other than the 
perceived life satisfaction which increased following child birth in both groups (S Fig 2). The 
significance of the anxiety subsection of the HADS at the postpartum visit was reduced after 
adjusting for maternal factors (P
2
, Table 3). Higher postnatal anxiety symptoms, in SO 
mothers were dependent on earlier anxiety symptoms during pregnancy, but not depression 
symptoms (P
7
, Table 3). 
  
Inverted U-shape relationship between GWG and maternal mood symptoms 
No linear correlations between maternal mood symptoms at week 17 pregnancy and total 
GWG were found in either group. Mood symptoms formed an inverted U-shaped relationship 
with total GWG (Fig 1). At (z) anxiety and (z) depression symptoms = 0, GWG of both 
groups was within the 2009 IOM guideline recommendations, but were below the guideline 
with lower and higher levels of A&D symptoms. Both (z) anxiety and (z) depression 
symptoms were correlated significantly with GWG in SO group, whereas only the (z) 
depression symptoms were correlated significantly with GWG in the controls. The majority 
of the scatters with (z) depression symptoms ≤ 0 aggregated very tightly, implying that the 
majority of the correlation was due to participants with higher depression symptoms. Overall 
Fig 1 implies that either low or high maternal symptoms of anxiety and/or depression result 
in lower total GWG than the 2009 IOM guideline, particularly in SO women. 
 
Maternal mood symptoms are associated with increased PPWR in SO group, 
independent of total GWG and breastfeeding 
SO group had significantly lower PPWR and lower proportion of breastfeeding at the 
postnatal visit as compared to the controls (Table 1). Increased PPWR was associated with 
increased maternal A&D symptoms at week 17 pregnancy in SO group, but not in the 
controls (S Table 4). Therefore regression analyses were performed in SO group only. Table 
4 shows that increased maternal A&D symptoms at week 17 pregnancy were associated with 
significantly increased PPWR in SO group, independent of total GWG and breastfeeding. 
 
The associations of increased A&D symptoms in maternal SO with GWG and PPWR 
are independent of circulating glucocorticoids 
Serum cortisol levels were lower in pregnancy with SO (Table 1), consistent with our 
previous observations (Stirrat et al., 2014). In SO group, anxiety symptoms at week 17 
pregnancy formed an inverted U-shape correlation with serum cortisol level at late gestation 
such that cortisol levels were lowest in those with the lowest or highest anxiety symptoms 
(Fig 2). Serum cortisol level at week 28 pregnancy formed a U-shape relationship with total 
GWG in SO group such that lowest and highest cortisol levels were associated with greatest 
GWG (R
2
=0.051, p=0.03). Increased serum cortisol level at week 36 pregnancy was 
associated with increased PPWR in SO group in adjusted analyses (β= -0.45, p=0.03). A 
mediation analysis showed that serum cortisol level did not mediate the association of anxiety 
symptoms with total GWG (p=0.08) or with PPWR (p=0.50) in SO women. 
Serum cortisol levels were not related to depression symptoms in SO, and no 
correlations were observed in lean group. Serum cortisol level at week 28 pregnancy was 
associated with reduced total GWG in controls in unadjusted and adjusted analyses (r=1.9, 
p<0.05; β=-2.2, p<0.05, respectively). There were no associations between cortisol levels and 
PPWR in lean women. 
 
 
  
Discussion 
In this prospective case-control study, we demonstrated for the first time that maternal SO is 
associated with higher antenatal and postnatal A&D symptoms compared with normal-weight 
controls, independent of a large number of confounders including several maternal and 
pregnancy factors and previous mental health diagnosis. We further showed the adverse 
associations between anxiety symptoms in early pregnancy and weight outcomes were not 
mediated by serum cortisol levels. 
Many of the anxiety, but not depression outcomes, were attenuated after adjusting for 
pregnancy factors, implying that the majority of antenatal anxiety symptoms were pregnancy-
specific, and can therefore be targeted for intervention during pregnancy. In contrast to 
findings in an intervention trial using motivational interview in an obese (BMI>30 kg/m
2
) 
pregnant cohort from the Netherlands (Bogaerts et al., 2013b), we did not find significant 
changes in the STAI scores in SO women during the course of pregnancy. This was unlikely 
due to the higher severity of obesity in our cohort, as the mean STAI scores were similar to 
those of the women in the Netherlands cohort (Bogaerts et al., 2013b). A decrease of anxiety 
symptoms therefore seems achievable only when they are specifically addressed during 
antenatal care. 
On the other hand, the higher antenatal GHQ scores in SO group as compared to 
controls, which remained significant following adjustments for multiple confounders, 
indicates that depression symptoms are not pregnancy-specific. Whilst the antenatal care 
given in our study and the motivational interview in the Netherland cohort (Bogaerts et al., 
2013b) appear sufficient in preventing the aggravation of depression symptoms, it also 
implies that a more specific pharmacological or behavioural intervention such as counselling 
and/or cognitive behavioural therapy may be required to significantly reduce depression 
symptoms in obese pregnant women. 
Our findings support the view that antenatal anxiety is one of the leading risk factors 
for postnatal anxiety disorders (Lancaster et al., 2010). Although antenatal depression 
symptoms remain a major risk factor for postpartum depression, our findings support the 
argument that postpartum depression has a distinct aetiology (birth and parenting) from 
antenatal depression (demographic factors). Ultimately antenatal mood symptoms in a 
vulnerable subpopulation such as SO pregnant women should be highlighted to health care 
professionals to help prevent possible postpartum mood disorders, and hopefully improve 
maternal and infant wellbeing. 
In considering whether an intervention in early pregnancy could prevent the potential 
negative effect of antenatal mood symptoms, we evaluated the link between maternal mood 
symptoms at the first visit (week 17 pregnancy) and pregnancy outcomes. The non-linear 
correlation between maternal mood and GWG may partly explain the previous conflicting 
literature about mood and GWG in women with different levels of obesity (Rauh et al., 2013; 
Guelinckx et al., 2010). However, it appears to be more physiologically relevant in the SO 
group as the proportion of pregnant women with high mood symptoms and the magnitude of 
total GWG deviation from the IOM guidelines was greater in SO group as compared to 
controls. Mothers with SO and lower levels of A&D symptoms may have possibly invested 
greater effort in managing their diet, resulting in less GWG. Nevertheless, the management of 
obese pregnancies should strongly consider addressing A&D symptoms since the more 
extreme the mood symptoms, the further the total GWG deviated from that of women with 
average levels of mood symptoms.  
The association between antenatal A&D symptoms and PPWR has not been 
previously reported in obese pregnancy. Bogaerts et al (2013a) recently reported the 
association between antenatal anxiety symptoms, but not depression symptoms, with 
increased PPWR in obese women. But unlike our study, Bogaerts et al (2013a) study lacked 
healthy weight controls and the participants were less severely obese (BMI = 34.4 kg/m
2
).  
Both the non-linear correlation between maternal A&D symptoms and GWG and the lack of 
a specific intervention for mood symptoms may explain why lifestyle interventions targeting 
GWG and/or PPWR have had limited success so far (Gardner et al., 2011). 
The findings in a meta-analyses in a non-pregnant population, where acute stress 
promotes increased cortisol levels (Dickerson and Kemeny, 2004) but prolonged stress 
promotes blunted cortisol reactivity, resulting in lower systemic cortisol (Burke et al., 2005), 
may explain the inverted U-shape correlation between anxiety symptoms, but not depression, 
and serum cortisol level at late gestation. Such a time-specific correlation is likely to be due 
to the transforming maternal HPA axis during early pregnancy (Pasquali et al., 1993), 
together with a higher trajectory of cortisol level with anxiety in pregnancy (Kane et al., 
2014) and the generally lower levels of circulating cortisol in SO women as compared to 
controls. The U-shape correlation between cortisol levels and GWG found in the SO group 
was unexpected and was in contrast to the inverse linear relation observed in the lean women. 
A recent observation showed obese pregnant women with excessive GWG had the highest 
evening cortisol levels as compared to lean women (Aubuchon-Endsley et al., 2014). 
However, we did not observe any direct mediation by cortisol of the links between A&D 
symptoms on either GWG or PPWR. Future studies should consider the assessment of free 
cortisol, daily profiling, and/or the circadian, placental and foetal effects on the maternal 
HPA axis. 
The main strength of our study is the prospective study design. The detailed 
characterisation of women during pregnancy enabled us to adjust for multiple important risk 
factors that have not been considered simultaneously in pregnancy such as sleep disordered 
breathings, infertility and inflammation disorders. Furthermore, the very clear differences in 
obesity levels between our SO and control group enabled us to determine independent effects 
of obesity, unlike other studies with overweight and less severely obese women (Molyneaux 
et al., 2014).  The higher proportion of deprivation among the SO mothers than in the lean 
group is a limitation, nevertheless this is consistent with findings from the UK national 
survey where maternal obesity correlates with deprivation and income level (Heslehurst et al., 
2010) and we adjusted all analyses for deprivation category. The total GWG, which as 
calculated between 17 and 36 weeks of gestation, may have underestimated the actual total 
GWG as defined by the IOM. However since the total GWG at (z) score anxiety and 
depression = 0 was within the IOM guideline in both groups, this did not seem to pose 
significant problems. 
We were limited by the 30% attrition rate at postnatal follow-up, though this was 
similar in both lean and SO groups. Of note, those who did not attend for follow-up had 
poorer mood scores than those who did, particularly in the SO group and so it is likely that 
we may have underestimated the post-partum mood differences between groups. We were 
unable to define PPWR by subtracting postnatal weight with weight preceding the pregnancy 
as these data were unavailable. However our calculation of PPWR was free from any bias of 
maternal recall. We could not segregate exclusive breastfeeding from mixed breast/bottle 
feeding as the proportion of exclusive breastfeeding was very low, even in the controls. This 
has not been previously discussed (Bogaerts et al., 2013a). 
 
In conclusion, SO during pregnancy is associated with significantly poorer antenatal and 
postnatal maternal mood symptoms. Both anxiety and depression symptoms formed an 
inverted U-shape relationship with total GWG where either few or several adverse mood 
symptoms was associated with less total GWG. This information should inform strategies to 
optimise GWG in SO women. 
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Figure Captions 
 
Figure 1 Anxiety and depression symptoms in week 17 pregnancy correlate non-linearly 
with total Gestational Weight Gain.  
Total Gestational Weight Gain = Weight (kg) at week 36- week 17 pregnancy. (Z)Anxiety 
symptoms = average of (z) HA and (z) STAI. (Z)Depression symptoms = average (z) HD and 
(z) GHQ. The 2009 IOM guideline for lean group = 11-16 kg, and for SO group = 5-9 kg. 
SO: Severely Obese. 
 
Figure 2 Anxiety symptoms are correlated non-linearly with the level of serum cortisol 
at week 36 pregnancy in severely obese women.  
R
2
 = the coefficient of correlation, the curve-fitting result of the quadratic function. No 
significant linear correlation was found. 
  
Tables 
Table 1 Maternal body composition, gestational age at visit and demographics 
1
For 
further analysis the log-transformed serum cortisol levels were used. 
2
Others include eczema, 
rheumatoid arthritis, multiple sclerosis and Crohn’s disease. Bold-Italic texts are significant 
at 0.05 level, underlined texts are significant at 0.1 level. SO: Severely Obese; ESS: Epworth 
Sleepiness Scale; IVF: In Vitro Fertilisation; PCOS: Polycystic Ovarian Syndrome. P value 
for body composition measures changes during pregnancy. Statistical tests include 
a 
t-test, 
b 
chi-square, 
c
 Mann-Whitney,
 d Fisher’s Exact. *Deprivation Category (McLoone, 2004), 
**One alcohol unit follows the NHS guideline. Bold-Italic texts are significant at 0.05 levels. 
Underlined texts are significant at 0.1 levels. 
 
Table 2 Mental health demographics 
1
The tabulation only includes participants with 
previous diagnosis of mental health disorders. 
2
The tabulation only includes participants with 
active mental health disorders at 1
st
 antenatal booking. SO: Severely Obese, p (χ2): P value 
Chi-square and/or Fisher’s- Exact test. Bold-Italic texts are significant at 0.05 levels 
 
 
 
 
 
 
Table 3 Psychosocial stress, survey on consulting GP regarding mental health, and 
mood assessments of research participants throughout pregnancy and at postnatal stage 
P
1
 was obtained from 
a 
chi-square test,
 b Fisher’s Exact test, c Mann-Whitney Test and d 
unpaired t-test. Linear regression was used to obtain P
2
 P
3
 and P
4
. SO: Severely Obese, Preg: 
Pregnancy, PN: postnatal. Bold-Italic texts are significant at 0.05 levels. Underlined texts are 
significant at 0.1 levels. 
1
 unadjusted 
2
 adjusted for maternal factors prior to current pregnancy: age, smoking status, alcohol 
consumption (unit/week), parity, deprivation category 
3
 adjusted for maternal factors arising during pregnancy: minor complications, GDM, risks 
of sleep apnoea, differences of gestational visit time between lean and obese groups at visit 1 
and postnatal 
4
 adjusted for factors in P
2
 and P
3
, 
5
 adjusted for previous history of mental health diagnosis, 
6
 
after omitting individuals with previous history of mental health diagnosis. 
7
 P
5
 adjusted for the results of anxiety or depression symptom assessment in pregnancy 
 
Table 4 Increased maternal anxiety and depression symptoms in week 17 pregnancy are 
associated with increased postpartum weight retention in Severely Obese (SO) group. 
Postpartum weight retention = - (Postnatal weight loss). P
1
: All demographic factors as 
defined in the demographic table and time- points at postnatal visits; P
2
: demographic factors 
+ breastfeeding; P
3
: demographic factors + breastfeeding + total Gestational Weight Gain. 
Bold-Italic texts are significant at 0.05 levels. Underlined texts are significant at 0.1 levels. 
 
 
Table 1 
Demographics Lean (n = 135) SO (n = 222) P value 
Body composition at visit 1, mean 
(SD) 
Weight (kg) 63.3 (6.8) 119.3 (14.9) ≤ 0.0001a 
BMI (kg/m2) 22.8 (1.7) 44.2 (4.1) ≤ 0.0001a 
BP- systolic (mmHg) 105.9 (8.8) 117.3 (9.9) ≤ 0.0001a 
BP- diastolic (mmHg) 63.1 (6.8) 69.9 (7.3) ≤ 0.0001a 
Gestational age (weeks) & 
postnatal age (months) at visit 
Visit 1 (mean in weeks + days, CI[95%]) 17+4 (17- 18) 18+4 (18+2- 19+2) 0.0004a 
Visit 2 (mean in weeks + days, CI[95%]) 29 (28+4 - 29+3) 28+6 (28+2- 29+3) 0.646a 
Postnatal (mean in months, CI[95%]) 3.9 (3.6- 4.1) 4.1 (3.8- 4.5) ≤0.0001a 
Total Gestational Weight Gain (kg) 
Mean (SD) 9.59 (3.85) 5.73 (5.07) ≤ 0.0001a 
According to the 2009 IOM 
recommendation, week 36- 
17 pregnancy 
Below 88 (67.69) 84 (43.75) 
≤ 0.0001b Within 34 (26.15) 63 (32.81) 
Above 8 (6.15) 45 (23.44) 
Postpartum weight retention (kg) 
Week 36 pregnancy- postpartum, mean 
(SD) 
9.5 (3.65) 6.77 (6.17) ≤ 0.0001a 
Serum cortisol level, nmol/l1 
Week 17 pregnancy, mean  (SD) 1555.29 (977.97) 1386.18 (1074.39) 0.007c 
Week 28 pregnancy, mean  (SD) 2387.84 (3786.24) 1834.36 (1141.25) 0.001c 
Week 36 pregnancy, mean  (SD) 2118.97 (924.19) 1867.11 (965.82) 0.001c 
Age in years, mean (SD) 33.4 (4.5) 31.4 (5.2) 0.0003a 
Parity, n (%) 
0 85 (63) 106 (48) 
0.02b 1 40 (30) 76 (34) 
≥2 10(7) 40 (18) 
Deprivation category*, n (%) 
Affluent-intermediate (1- 3) 91 (67.4) 67 (30.3) 
≤0.0001d 
Deprived – very deprived (4- 7) 54 (32.6) 155 (69.8) 
Ethnicity, n (%) 
Caucasian 132 (97.8) 210 (94.6) 
0.721d 
Others 3 (2.2) 12 (5.4) 
Smoking status during pregnancy, 
n (%) 
Never 77 (57) 124 (56.1) 
0.025b Ex-smoker 54 (40) 69 (31.2) 
Currently smoking 4 (3) 28 (12.7) 
Alcohol consumption before 
pregnancy 
Unit/week, median (range)** 6 (0-30) 2 (0-30) ≤0.0001c 
Undeclared, n (%) 7 (5.2) 85 (38.3) ≤0.0001d 
Alcohol consumption during 
pregnancy 
Not consuming, n (%) 125 (57) 181 (81.5) 
0.001d 
Undeclared, n (%) 81 (37.5) 33 (14.9) 
Unit/week, median (range)** 0 (0-11) 0 (0-10) 0.242c 
Infertility factors, n (%) 
Fertility drug 7 (6.7) 3 (1.4) 0.118d 
IVF 9 (5.2) 3 (1.4) 0.212d 
PCOS 8 (5.9) 20 (9) 0.593d 
Previous pregnancy loss 
Miscarriage ≥1, n (%) 40 (22.2) 109 (26.3) 0.629d 
Ectopic, molar, stillbirth ≥1, n (%) 1 (0.7) 6 (2.8) 0.626d 
Termination ≥1, n (%) 15 (11) 30 (14) 0.670d 
Minor obstetric complications, ≥ 5 out of 9 syndromes, n (%) 10 (7.8) 46 (21.8) 0.012b 
Preeclampsia, n (%) 4 (3) 21 (9.5) 0.082d 
Gestational Diabetes Mellitus, n (%) 3 (2.2) 45 (20.4) ≤0.0001d 
Medical disorders, n (%) 
Asthma 19( 14.1) 48 (21.6) 
0.487b Hypothyroidism 1 (0.7) 15 (6.8) 
Others2 2 (2.2) 6 (2.8) 
Risk of sleep disordered breathing, 
n (%) 
Berlin Questionnaire 6 (6.4) 99 (73.6) ≤0.0001d 
ESS, cut-off <10 (47) 16 (16.8) 34 (24) 0.224d 
Both 2 (3.2) 30 (22.3) ≤0.0001d 
Exclusive and mixed breastfeeding at postpartum visit of mood assessments, n 
(%) 
94 (78) 56 (29) ≤0.0001d 
 
 
Table 2 
Previous mental health demographics Lean (n = 135) SO (n = 222) P (χ2) 
H
o
sp
it
al
 r
e
co
rd
s 
Previous diagnosis of mental health disorders, n (%) 
Yes 23 (17) 78 (35.5) 0.006 
Types of mental health diagnosis, n (%) 
Anxiety 4 (17.4) 9 (11.5) 
0.002 
Depression 8 (34.8) 47 (60.3) 
Previous postnatal depression 4 (17.4) 13 (16.7) 
Anxiety & Depression 3 (13.0) 8 (10.3) 
Anorexia and Bulimia 4 (17.4) 1 (1.3) 
Status of mental health disorders at 1st antenatal booking 1, n (%) 
Inactive 7 (30.4) 18 (23.1) 
0.336 
Active 16 (69.6) 60 (76.9) 
Anti-depressant status at 1st antenatal booking 2, n (%) 
Discontinued 5 (31.3) 24 (40) 
0.411 Continued 3 (18.8) 10 (16.7) 
Counselling only 8 (50) 26 (43.3) 
Q
u
e
st
io
n
n
ai
re
  “Have you consulted GP about mental health in the last 2 years?” n (%) 
Yes 12 (9.25) 120 (54.1) 
≤ 0.0001 No 108 (80) 46 (20.7) 
Did not answer 15 (10.75) 56 (25.25) 
 
Table 3 
Psychosocial stress, n (%) 
Lean SO 
P1 P2 P3 P4 P5 P6 
Pregnancy PN Pregnancy PN 
Work 
Never 9 (7.5) 7 (9.6) 24 (14.65) 9 (11.5) 
a0.037preg 
a0.435PN 
0.612preg 
0.461PN 
0.079preg 
0.586PN 
0.593preg 
0.461PN 
0.618preg 
0.488PN 
0.156preg 
0.943PN 
Some periods 64 (53.1) 40 (54.8) 61 (37.05) 37 (47.4) 
Several periods 41 (34.05) 15 (20.5) 54 (33.1) 15 (19.2) 
Permanently 3 (2.5) 1 (1.4) 7 (4.25) 4 (5.1) 
Not working 3 (2.95) 10 (13.7) 18 (10.95) 13 (16.7) 
Home 
Never 26 (22) 11 (15.1) 27 (16.6) 7 (9) 
a0.164preg 
a0.359PN 
0.476preg 
0.048PN 
0.195preg 
0.137PN 
0.769preg 
0.029PN 
0.506preg 
0.038PN 
0.606preg 
0.027PN 
Some periods 78 (65.15) 48 (65.8) 99 (59.6) 51 (65.4) 
Several periods 14 (12.05) 14 (19.2) 36 (21.95) 19 (24.4) 
Permanently 1 (0.8) 0 3 (1.8) 1 (1.3) 
Finance 
Little or none 70 (58.45) 40 (54.8) 67 (40.7) 28 (35.9) 
a0.011preg 
a0.020PN 
0.022preg 
0.002PN 
0.001preg 
0.002PN 
0.007preg 
0.002PN 
0.013preg 
0.004PN 
0.249preg 
0.003PN 
Moderate 47 (39.05) 30 (41.1) 78 (47.25) 43 (55.1) 
High or severe 3 (2.5) 3 (4.1) 20 (12.05) 7 (9) 
Life events 
None 90 (74.75) 55 (75) 91 (54.65) 43 (55) b0.005preg 
b0.005PN 
0.233preg 
0.03PN 
0.118preg 
0.021PN 
0.633preg 
0.005PN 
0.982preg 
0.021PN 
0.545preg 
0.003PN 1 or more 30 (25.25) 18 (25) 75 (45.35) 35 (45) 
Mood assessments Lean SO P1 P2 P3 P4 P5 P6 P7 
Satisfaction With Life Scale in median (range), possible scores: 5-35 
Visit 1 29 (7-35) 25 (5-35) ≤ 0.0001c ≤ 0.0001 ≤ 0.0001 ≤ 0.0001 0.001 0.22 - 
Visit 2 30 (9-35) 26 (9-35) ≤ 0.0001c 0.024 0.225 0.052 0.049 0.062 - 
Postnatal 30 (18-35) 28 (12-35) ≤ 0.0001c ≤ 0.0001 ≤ 0.0001 ≤ 0.0001 ≤ 0.0001 0.002 0.319 
Hospital Anxiety Depression Scale in mean (SD), possible scores: 0-21 per component 
Anxiety 
Visit 1 5.16 (2.79) 5.82 (3.43) 0.081d 0.448 0.262 0.442 0.804 0.033 - 
Visit 2 4.97 (2.68) 5.98 (3.48) 0.009d 0.018 0.354 0.085 0.077 0.086 - 
Postnatal 4.39 (3.11) 5.77 (3.86) 0.020d 0.142 0.004 0.088 0.113 0.028 0.197 
Depression 
Visit 1 2.15 (2.13) 3.69 (3.22) ≤ 0.0001d 0.006 ≤ 0.0001 0.003 0.007 0.202 - 
Visit 2 2.05 (1.74) 3.91 (3.13) ≤ 0.0001d 0.019 0.38 0.092 0.085 0.084 - 
Postnatal 2.07 (1.79) 3.32 (2.86) 0.002d 0.02 0.001 0.01 0.013 0.012 0.043 
State- Trait Anxiety Index in mean (SD), possible scores: 20-80 per component 
State 
Visit 1 28.78 (8.55) 33.83 (10.44) ≤ 0.0001d 0.009 0.001 0.022 0.066 0.075 - 
Visit 2 28.61 (7.84) 34.10 (10.37) ≤ 0.0001d 0.006 ≤ 0.0001 0.003 0.006 0.008 - 
Postnatal 28.16 (7.7) 32.23 (9.73) 0.006d 0.019 ≤ 0.0001 0.011 0.014 0.007 0.748 
Trait 
Visit 1 32.66 (8.99) 36.49 (11.55) 0.003d 0.119 0.019 0.1 0.26 0.19 - 
Visit 2 32.17 (7.91) 36.30 (11.3) 0.001d 0.142 0.015 0.085 0.13 0.036 - 
Postnatal 30.94 (8.41) 35.25 (10.81) 0.009d 0.006 0.001 0.036 0.056 0.017 0.817 
General Health Questionnaire in mean (SD), possible scores: 0-15 
Visit 1 1.62 (1.92) 3.21 (2.75) ≤ 0.0001d ≤ 0.0001 ≤ 0.0001 ≤ 0.0001 ≤ 0.0001 0.039 - 
Visit 2 1.75 (1.79) 3.36 (2.92) ≤ 0.0001d 0.001 ≤ 0.0001 0.001 0.003 0.002 - 
Postnatal 1.29 (1.24) 2.74 (2.16) ≤ 0.0001d ≤ 0.0001 ≤ 0.0001 0.001 0.001 0.004 0.04 
 
  
 Table 4 
Postnatal weight loss (SO group),  (p) P
1 P2 P3 
Week 17 pregnancy 
(z) Anxiety symptoms -0.33 (0.04) -0.33 (0.04) -0.33 (0.03) 
(z) Depression symptoms -0.21 (0.02) -0.21 (0.02) -0.19 (0.04) 
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Supplementary 
Supplementary Figure 1 CONSORT diagram of the study for the mood assessments 
during pregnancy and at postnatal. The upper limit of BMI is 60 kg/m2. 
 
Supplementary Figure 2 Participants were more satisfied with life following pregnancy 
and delivery. The bottom and top line of the bar represents minimum and maximum SWLS 
score, respectively. * P≤0.05. SO: Severely Obese. 
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 Supplementary Table 1 The poorer mood outcome in SO group was still observed in z-
score format 
HIP study pool (n = 344) 
Mean (SD) week 17 week 28 p 
Anx 
Lean -0.26 (0.81) -0.29 (0.72) 
≤0.0001 
SO 0.16 (0.96) 0.18 (0.98) 
Dep 
Lean -0.40 (0.72) -0.42 (0.63) 
≤0.0001 
SO 0.24 (0.96) 0.25 (0.99) 
 
SO: Severely Obese. Anx: averaged z-scores of anxiety outcomes, Dep: averaged z-scores of 
depression outcomes. 
  
Supplementary Table 2 Mood assessment cut-off scores of research participants 
throughout pregnancy.   
 
Mood  assessments Lean SO P1 P2 P3 P4 
Satisfaction with Life Scale score ≤19, slightly below average (41) 
visit1, n (%) 10 (8.2) 38 (22.89) 0.001 0.015 0.002 0.008 
visit2, n (%) 5 (4.2) 30 (17.75) ≤ 0.0001 0.032 0.025 0.039 
Postnatal, n (%) 2 (2.78) 6 (9.09) 0.152 0.075 0.095 0.925 
Hospital Anxiety Depression Scale score ≥10 (38) 
Anxiety             
visit1, n (%) 10 (8.2) 24 (14.63) 0.139 0.44 0.242 0.202 
visit2, n (%) 7 (6.25) 30 (17.86) 0.004 0.303 0.028 0.456 
Postnatal, n (%) 3 (4.17) 13 (18.57) 0.008 0.659 0.012 0.49 
Depression             
visit1, n (%) 2 (1.64) 10 (6.14) 0.076 0.887 0.238 0.684 
visit2, n (%) 1 (0.84) 9 (5.36) 0.05 0.535 0.678 0.884 
Postnatal, n (%) 0 (0) 4 (5.8) 0.055 0.165 0.13 0.978 
State Trait Anxiety Index score ≥39, from validation study of female population (39) 
State             
visit1, n (%) 13 (10.83) 45 (27.78) 0.001 0.023 0.005 0.033 
visit2, n (%) 15 (12.6) 46 (27.87) 0.002 0.044 0.013 0.053 
Postnatal, n (%) 9 (13) 20 (25.97) 0.062 0.118 0.002 0.017 
Trait             
visit1, n (%) 25 (21) 54 (33.13) 0.031 0.096 0.093 0.058 
visit2, n (%) 24 (20.5) 59 (35.75) 0.008 0.428 0.027 0.399 
Postnatal, n (%) 11 (16.18) 22 (28.57) 0.112 0.033 0.029 0.075 
General Health Questionnaire score ≥3, a suggested cut-off for further screening (42) 
visit1, n (%) 23 (18.7) 87 (53.05) ≤ 0.0001 ≤ 0.0001 ≤ 0.0001 ≤ 0.0001 
visit2, n (%) 32 (26.89) 85 (50.3) ≤ 0.0001 0.002 0.003 0.006 
Postnatal, n (%) 12 (17.14) 34 (50) ≤ 0.0001 0.007 ≤ 0.0001 0.023 
 
P
1 was obtained from Fisher’s Exact Test. Logistic regression was used to obtain P2 P3 and 
P
4
. SO: Severely Obese. OR: Odd Ratio, CI: Confidence Interval Bold-Italic texts are 
significant at 0.05 levels, underlined text are significant at 0.1 levels. The cut-off scores are 
recommended scores for further clinical diagnosis. 
1
 unadjusted 
2
 adjusted for maternal factors prior to current pregnancy: age, smoking status, alcohol 
consumption (unit/week), parity, deprivation category 
3
 adjusted for maternal factors arising during pregnancy: minor complications, GDM, risks 
of sleep apnoea, differences of gestational visit time between lean and obese groups at visit 1 
and postnatal 
4
 adjusted for factors in P
2
 and P
3
,  
 
  
Supplementary Table 3 Differences in mood scores during pregnancy between mothers 
who attended for follow-up and those who did not.  
Mood 
Assessments 
Attended postnatal follow-up Declined postnatal follow-up p value (t-test) 
Lean SO All Lean SO All Lean SO All 
vi
si
t 
1
 
SWLS 28.05 (5.45) 24.94 (5.95) 26.34 (5.92) 27.73 (1.31) 22.76 (7.05) 24.47 (7.11) 0.806 0.055 0.036 
HA 5.05 (2.65) 5.64 (3.44) 5.38 (3.12) 5.73 (0.71) 6.33 (3.56) 6.11 (3.46) 0.307 0.283 0.112 
HD 1.91 (1.87) 3.52 (3.22) 2.8 (2.81) 3.27 (0.61) 4.25 (3.35) 3.9 (3.20) 0.007 0.223 0.009 
State 28.15 (7.69) 33.07 (10.50) 30.86 (9.64) 31.77 (2.45) 35.86 (10.48) 34.45 (10.93) 0.076 0.143 0.012 
Trait 32.45 (8.78) 35.52 (11.22) 34.15 (10.29) 34.09 (2.24) 39.17 (12.51) 37.48 (11.98) 0.455 0.083 0.032 
GHQ 1.5 (1.77) 2.97 (2.71) 2.31 (2.44) 2.27 (0.55) 3.95 (2.86) 3.37 (2.86) 0.097 0.050 0.004 
vi
si
t 
2
 
SWLS 28.64 (4.53) 25.64 (5.14) 26.99 (5.09) 30 (0.99) 23.19 (6.14) 25.27 (6.44) 0.232 0.012 0.028 
HA 5 (2.71) 5.76 (3.34) 5.42 (3.09) 5 (0.62) 6.58 (3.89) 6.1 (3.62) 1.000 0.191 0.144 
HD 2.01 (1.81) 3.28 (2.66) 2.7 (2.39) 2.26 (0.32) 5.63 (3.68) 4.6 (3.52) 0.567 0.000 0.000 
State 28.59 (8.00) 32.86 (9.70) 30.93 (9.20) 29.47 (1.63) 37.53 (11.62) 34.93 (10.99) 0.656 0.013 0.005 
Trait 32.18 (8.08) 35.20 (10.88) 33.85 (9.82) 33.17 (1.59) 39.7 (12.37) 37.67 (11.28) 0.629 0.030 0.011 
GHQ 1.68 (1.83) 3.05 (2.64) 2.44 (2.41) 2.16 (0.38) 4.19 (3.59) 3.56 (3.25) 0.295 0.030 0.003 
 
Mothers who attended postnatal follow-up reported less mood symptoms during pregnancy as 
compared to those who did not. SO: Severely Obese, Bold-Italic texts are significant at 0.05 
levels. Displayed values are mean (SD). 
  
 Supplementary Table 4 Increased maternal anxiety and depression symptoms in week 
17 pregnancy were correlated with increased postpartum weight retention in Severely 
Obese (SO) group, but not in the controls. Postpartum weight retention = - (Postnatal weight 
loss), ** p≤ 0.01, *p ≤ 0.05.  
Postnatal weight loss, Pearson's R (p) Lean SO 
Week 17 pregnancy 
(z) Anxiety symptoms 0.07 -0.24** 
(z) Depression symptoms 0.06 -0.22* 
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